Prostate cancer | Page 13 of 18

Prostate Cancer :: Prostate cancer – speeding development of novel tracer

The collaborative work being performed by professionals across medical disciplines in the promising area of molecular imaging — from research scientists to nuclear medicine physicians, urologists, radiochemists and even veterinarians — provides encouraging news in fighting prostate cancer. This type of progressive — or translational — research can be seen in two papers published in the January issue of the Journal of Nuclear Medicine.

Prostate Cancer :: Study suggests role for Y chromosome in prostate cancer

A new study finds that, among a group of men in Israel, men with only daughters had a 40 percent higher risk of prostate cancer than men with at least one son. The study raises the possibility that some mutation or variant on the Y chromosome may be involved in prostate cancer.

Prostate Cancer :: Prostate cancer treatment costly $42,570

A new study reveals that the cumulative cost of prostate cancer is, on average, $42,570 over five years. Watchful waiting was the least expensive treatment while radiation and androgen deprivation therapy were the most expensive.

Prostate Cancer :: Statin use decreases prostate cancer risk

Use of cholesterol-lowering medications called statins is not associated with a lower risk of prostate cancer overall, but it is associated with a decreased risk of advanced disease, a large prospective study finds.

Prostate Cancer :: older men with early prostate cancer treated lived longer

SEER-Medicare analysis finds older men with early prostate cancer who were treated lived longer than those who were not treated. Study published in Dec. 13th issue of JAMA.

Prostate Cancer :: Older men treated for early prostate cancer live longer than those who are not

Recent findings of an observational study by researchers at the University of Pennsylvania School of Medicine suggest that men between 65-80 years of age who received treatment for early stage, localized prostate cancer lived significantly longer than men who did not receive treatment. The study will be published in the Dec. 13 issue of JAMA.

Prostate Cancer :: Prescribing inconsistencies in prostate cancer treatment in the UK when using LHRHAs

Majority of healthcare professionals surveyed agree that patients with prostate cancer should receive a licensed treatment wherever possible.

Prostate :: Aspirin reduces enlarged prostate problems and BHP

Scientists at the Mayo Clinic in Minnesota found that taking aspirin and other similar painkillers, may reduce the risk of developing an enlarged prostate by at least 50 percent.

Prostate Cancer :: Hair growth drug lowers PSA prostate specific antigen

The popular hair-growth drug Propecia? taken by millions of balding men, artificially lowers the results of the prostate-specific antigen (PSA) test, the standard screening test for prostate cancer, researchers report.

Prostate Cancer :: African-Americans with prostate cancer more likely to have family history of prostate, breast cancer

African-American men with prostate cancer were more likely to report a family history of prostate cancer and breast cancer among siblings than men who did not have prostate cancer, according to researchers at the University of Michigan Comprehensive Cancer Center.